Tempus and Medtronic Announce ALERT Trial Results Showing AI-Driven EHR Notifications Improve Treatment for Significant Valvular Heart Disease

Go back to Tempus and Medtronic Announce ALERT Trial Results Showing AI-Driven EHR Notifications Improve Treatment for Significant Valvular Heart Disease
StemCells, Inc. (NASDAQ: TEM) Delayed: 48.61 +0.76 (1.59%)
Previous Close $47.85    52 Week High $0.45 
Open $47.00    52 Week Low $0.37 
Day High $49.85    P/E N/A 
Day Low $46.68    EPS $-0.31 
Volume 5,325,349